Ursodeoxycholic acid is associated with improved long-term outcome in patients with primary sclerosing cholangitis

被引：0
|
作者：
Toshihiko Arizumi
Susumu Tazuma
Hiroyuki Isayama
Takahiro Nakazawa
Toshio Tsuyuguchi
Hajime Takikawa
Atsushi Tanaka
机构：
[1] Teikyo University School of Medicine,Department of Medicine
[2] Hiroshima University,Department of General Internal Medicine, Graduate School of Biomedical & Health Sciences
[3] Juntendo University,Department of Gastroenterology, Graduate School of Medicine
[4] Nagoya City University,Department of Gastroenterology
[5] Chiba University,Department of Medicine and Clinical Oncology, Graduate School of Medicine
[6] Teikyo University,Faculty of Medical Technology
来源：
Journal of Gastroenterology | 2022年 / 57卷
关键词：
Ursodeoxycholic acid; Long-term outcomes; Primary sclerosing cholangitis; Liver transplantation-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：902 / 912
页数：10
相关论文
共 50 条
  • [41] Long-term outcomes of liver transplantation for primary sclerosing cholangitis
    Harputluoglu, M. M.
    Calgin, M. Z.
    Bilgic, Y.
    Kutlu, R.
    Yilmaz, S.
    TRANSPLANTATION, 2022, 106 (8S) : 193 - 193
  • [42] Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
    Boberg, KM
    Bergquist, A
    Mitchell, S
    Pares, A
    Rosina, F
    Broome, U
    Chapman, R
    Fausa, O
    Rocca, G
    Schrumpf, E
    HEPATOLOGY, 2001, 34 (04) : 355A - 355A
  • [43] Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis
    Vratislav Smolka
    Eva Karaskova
    Oksana Tkachyk
    Kvetoslava Aiglova
    Jiri Ehrmann
    Kamila Michalkova
    Michal Konecny
    Jana Volejnikova
    Hepatobiliary & Pancreatic Diseases International, 2016, 15 (04) : 412 - 418
  • [44] Long-term follow-up of children and adolescents with primary sclerosing cholangitis and autoimmune sclerosing cholangitis
    Smolka, Vratislav
    Karaskova, Eva
    Tkachyk, Oksana
    Aiglova, Kvetoslava
    Ehrmann, Jiri
    Michalkova, Kamila
    Konecny, Michal
    Volejnikova, Jana
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2016, 15 (04) : 412 - 418
  • [45] Endoscopic dilation of dominant stenoses in primary sclerosing cholangitis: outcome after long-term treatment
    Gotthardt, Daniel N.
    Rudolph, Gerda
    Kloeters-Plachky, Petra
    Kulaksiz, Hasan
    Stiehl, Adolf
    GASTROINTESTINAL ENDOSCOPY, 2010, 71 (03) : 527 - 534
  • [46] HIGH DOSE URSODEOXYCHOLIC ACID IS ASSOCIATED WITH THE DEVELOPMENT OF COLORECTAL NEOPLASIA IN PATIENTS WITH ULCERATIVE COLITIS AND PRIMARY SCLEROSING CHOLANGITIS
    Eaton, John
    Silveira, Marina G.
    Lindor, Keith D.
    HEPATOLOGY, 2010, 52 (04) : 356A - 356A
  • [47] Serum cytokine levels in patients with primary sclerosing cholangitis: Effect of treatment with ursodeoxycholic acid
    Neuman, MG
    Angulo, P
    Malkiewicz, IM
    Jorgensen, RA
    Katz, GG
    De Silva, JP
    Lindor, KD
    JOURNAL OF HEPATOLOGY, 2001, 34 : 213 - 213
  • [48] Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?
    Chazouillères, O
    Corpechot, C
    NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY, 2006, 3 (05): : 248 - 249
  • [49] Ursodeoxycholic acid is not chemopreventive for colorectal cancer in ulcerative colitis patients with primary sclerosing cholangitis
    Wolf, JM
    Rybicki, L
    Lashner, BA
    GASTROENTEROLOGY, 2001, 120 (05) : A447 - A447
  • [50] Is high-dose ursodeoxycholic acid effective for the treatment of patients with primary sclerosing cholangitis?
    Olivier Chazouillères
    Christophe Corpechot
    Nature Clinical Practice Gastroenterology & Hepatology, 2006, 3 : 248 - 249
12345